...DGEN markets its DeltaBase and DeltaOne target validation services in metabolism and inflammation, and provides XenoPharm...

...of finance from controller. Hired: Jay Lichter as EVP of business development, formerly CEO of XenoPharm Inc. WIR...

...test an undisclosed number of BMY compounds for their induction of drug metabolism enzyme expression. XenoPharm...
...of compounds' abilities to induce expression of liver and intestinal genes, including the CYP3A4 gene. XenoPharm Inc....

...an undisclosed number of Bristol-Myers (BMY) compounds for their induction of drug metabolism enzyme expression. XenoPharm...

...formed company XenoPharm (San Diego, Calif.). William Schrader was appointed VP of research and CSO. XenoPharm...